FASLG and neoplasm: This upregulation en-hances the sensitivity of tumor cells to Fas ligand (FasL)-mediated apoptosis induced by CTLs and NK cells[196,197].These findings provide a novel rationale for combining NO donors with immunotherapy to improve anti-tumor immune responses.